Cargando…

Deep learning model for prediction of hepatocellular carcinoma in patients with HBV-related cirrhosis on antiviral therapy

BACKGROUND & AIMS: Personalised risk prediction of the development of hepatocellular carcinoma (HCC) among patients with liver cirrhosis on potent antiviral therapy is important for targeted screening and individualised intervention. This study aimed to develop and validate a new model for risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nam, Joon Yeul, Sinn, Dong Hyun, Bae, Junho, Jang, Eun Sun, Kim, Jin-Wook, Jeong, Sook-Hyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581930/ https://www.ncbi.nlm.nih.gov/pubmed/33117971 http://dx.doi.org/10.1016/j.jhepr.2020.100175

Ejemplares similares

A scoring system for predicting hepatocellular carcinoma risk in alcoholic cirrhosis
por: Lee, Kyunghan, et al.
Publicado: (2022)

Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels
por: Lee, Junggyu, et al.
Publicado: (2015)

Risk of Hepatocellular Carcinoma Remains High in Patients with HBV-Related Decompensated Cirrhosis and Long-Term Antiviral Therapy
por: Zhu, Dong-Mei, et al.
Publicado: (2020)

Novel Model to Predict HCC Recurrence after Liver Transplantation Obtained Using Deep Learning: A Multicenter Study
por: Nam, Joon Yeul, et al.
Publicado: (2020)

FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
por: Chen, Xiongfei, et al.
Publicado: (2020)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
por: Yu, Liang-He, et al.
Publicado: (2011)

Effectiveness of 4-Week Oral Taurine Treatment for Muscle Cramps in Patients with Liver Cirrhosis: A Single-Arm Pilot Study
por: Jang, Eun Sun, et al.
Publicado: (2021)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Deep Learning for the Pathologic Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma, and Metastatic Colorectal Cancer
por: Jang, Hyun-Jong, et al.
Publicado: (2023)

The Effect of Antiviral Therapy on Serum Cholesterol Levels in Chronic Hepatitis C
por: Jang, Eun Sun, et al.
Publicado: (2011)

Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients
por: Kim, Sehwa, et al.
Publicado: (2021)

A new model predicts hepatocellular carcinoma in patients with HBV-related decompensated liver cirrhosis and long-term antiviral therapy: a prospective study
por: Mao, Hao-dan, et al.
Publicado: (2023)

Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
por: Wang, Kai, et al.
Publicado: (2018)

The diagnosis and treatment of primary biliary cirrhosis
por: Kim, Kyung-Ah, et al.
Publicado: (2011)

Nucleoside analogs treatment delay the onset of hepatocellular carcinoma in patients with HBV-related cirrhosis
por: Bi, Jingfeng, et al.
Publicado: (2017)

Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis
por: Chung, Jung Wha, et al.
Publicado: (2014)

Prognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma
por: Choi, Gwang Hyeon, et al.
Publicado: (2021)

DeepHBV: a deep learning model to predict hepatitis B virus (HBV) integration sites
por: Wu, Canbiao, et al.
Publicado: (2021)

Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis
por: Jeon, Yejoo, et al.
Publicado: (2016)

Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
por: Chen, Jian-Lin, et al.
Publicado: (2016)

Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinoma
por: Liu, Jian, et al.
Publicado: (2023)

Epidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017: A Prospective Multicenter Cohort Study
por: Nam, Joon Yeul, et al.
Publicado: (2020)

Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma
por: Jang, Eun Sun, et al.
Publicado: (2016)

Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis
por: Li, Yaqun, et al.
Publicado: (2022)

Elevated Serum Vinculin in Patients with HBV/HCV-Associated Liver Cirrhosis and Hepatocellular Carcinoma: A Pilot Study
por: Essa, Abdallah, et al.
Publicado: (2023)

Antiviral therapy of chronic HBV infection in pregnancy
por: Nikolajuk-Stasiuk, Julita, et al.
Publicado: (2016)

Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis
por: Ioannou, George N., et al.
Publicado: (2020)

Impact of antiviral therapy with nucleos(t)ide analog on survival of patients with HBV-related small hepatocellular carcinomas
por: Wei, Yanyan, et al.
Publicado: (2019)

Reappraisal of the diagnostic value of alpha‐fetoprotein for surveillance of HBV‐related hepatocellular carcinoma in the era of antiviral therapy
por: Qian, Xiangjun, et al.
Publicado: (2020)

Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment
por: Lee, I-Cheng, et al.
Publicado: (2022)

Impact of Low Skeletal Muscle Mass on Long-Term Outcomes in Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization: A Retrospective Multi-Center Study
por: Nam, Heechul, et al.
Publicado: (2023)

Surveillance Rate and its Impact on Survival of Hepatocellular Carcinoma Patients in South Korea: A Cohort Study
por: Im, Sanghyuk, et al.
Publicado: (2019)

Immunologic Characterization of Posthepatitis Cirrhosis Caused by HBV and HCV Infection
por: Li, Wan-Yu, et al.
Publicado: (2010)

Serum potassium levels and prognosis in HBV‐associated decompensated cirrhosis
por: Huang, JianJiang, et al.
Publicado: (2021)

Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea
por: Kim, Jihye, et al.
Publicado: (2020)

The Levels of Ghrelin, Leptin, TNF-α, and IL-6 in Liver Cirrhosis and Hepatocellular Carcinoma due to HBV and HDV Infection
por: Ataseven, Huseyin, et al.
Publicado: (2006)

Coagulation Proteins Influencing Global Coagulation Assays in Cirrhosis: Hypercoagulability in Cirrhosis Assessed by Thrombomodulin-Induced Thrombin Generation Assay
por: Youngwon, Nam, et al.
Publicado: (2013)

Deep Sequencing Analysis of HBV Genotype Shift and Correlation with Antiviral Efficiency during Adefovir Dipivoxil Therapy
por: Wang, Yuwei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ddr1i302k9s9uirphtedl6e6pe